Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:01 PM

Cadrenal Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-10.65M -8.36M -6.71M
Depreciation & Amortization
1.88K 1.98K 1.27K
Stock-Based Compensation
1.42M 710.38K n/a
Other Working Capital
538.1K 381.89K 202.84K
Other Non-Cash Items
-352 3.97M 4.5M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
1.87M 144.31K 607.74K
Operating Cash Flow
-7.36M -3.53M -1.2M
Capital Expenditures
-6.54K -3.25K n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a -2.28K
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-6.54K -3.25K -2.28K
Debt Repayment
n/a -250K n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
3.84M 250K n/a
Financial Cash Flow
8.98M 11.9M 1.24M
Net Cash Flow
1.62M 8.37M 32.59K
Free Cash Flow
-7.36M -3.53M -1.2M